The exponential growth of genomic variants uncovered by next-generation sequencing necessitates efficient and accurate computational analyses to predict their functional effects. A number of computational methods have been developed for the task, but few unbiased comparisons of their performance are available. To fill the gap, The Critical Assessment of Genome Interpretation (CAGI) comprehensively assesses phenotypic predictions on newly collected experimental datasets. Here, we present the results of the SUMO conjugase challenge where participants were predicting functional effects of missense mutations in human SUMO-conjugating enzyme UBE2I.
INTRODUCTION
Ever-growing next-generation sequencing efforts identify copious missense variants that lead to single amino acid substitutions in proteins. Phenotypic effects for most of these variants are unknown, and their comprehensive functional studies are not feasible considering the scale. A number of computational methods have been developed to predict the effects of missense mutations and prioritize them for experimental work. These methods can be divided into three main categories: single predictors based on evolutionary considerations from sequence, single predictors deriving from additional information such as 3D structure and physicochemical attributes of amino acids, and metapredictors that integrate scores from several other predictors (Gnad, Baucom, Mukhyala, Manning, & Zhang, 2013; Miosge et al., 2015) . Compared with the abundance of prediction methods (Adebali, Reznik, Ory, & Zhulin, 2016; Adzhubei et al., 2010; Bromberg & Rost, 2007; Choi & Chan, 2015; Katsonis & Lichtarge, 2014; Kircher et al., 2014; Kumar, Henikoff, & Ng, 2009; Li et al., 2009; studies assessing their performance are scarce (Martelotto et al., 2014; Miosge et al., 2015; Schiemann & Stowell, 2016) . The reliability of previous assessments remains unclear because predictors perform inconsistently across benchmarks, which may indicate unintended overlap between training and testing data sets (Grimm et al., 2015) . Therefore, a community-wide experiment on de novo generated testing sets is required to: (1) objectively assess different predictors, (2) reveal the strengths and weaknesses of methods, (3) highlight the most promising trends in the field, and (4) provide guidance for people outside the field in choosing optimal methods.
Here, we evaluate the SUMO conjugase challenge in the Critical Assessment of Genome Interpretation (CAGI), in which participants were asked to predict the fitness effects of missense mutations in the human SUMO-conjugating enzyme (UBC9, also known as UBE2I).
UBE2I is the only known human SUMO ligase (E2 enzyme) that transfers SUMO from the E1 complex to downstream substrates through a conserved Cys residue. UBE2I recognizes substrates by their consensus motif and catalyzes the sumoylation reaction, which can be assisted by E3 ligases (Geiss-Friedlander & Melchior, 2007 cellular processes including protein degradation, cell proliferation, signal transduction, nuclear transport, and chromosome segregation (Flotho & Melchior, 2013; Gareau & Lima, 2010) . UBE2I regulates proliferation and transformation in different cancers and is targeted by multiple viruses, including HIV, EBV, and HPV (Everett, Boutell, & Hale, 2013; Jaber et al., 2009; Li, Lu, & Prochownik, 2007; Qin et al., 2011; Seeler & Dejean, 2017) . A large number of novel missense mutations in UBE2I have been identified recently in cancer patients, but their functional impact remains unclear (Wu et al., 2014) . Furthermore, high-resolution spatial structures of different macromolecular complexes of UBE2I with its substrates and regulators are available, enabling predictors to use extensive structural information (Alontaga et al., 2015; Bernier-Villamor, Sampson, Matunis, & Lima, 2002; Capili & Lima, 2007; Streich & Lima, 2016) . Therefore, UBE2I is an excellent target for testing computational predictions of mutational effects.
The dataset used here to assess predictions was a collection of functional impact scores for human UBE2I mutants measured in a companion study (Weile et al., unpublished results) . Briefly, effects of missense mutations in UBE2I were measured using a previously-described Saccharomyces cerevisiae (yeast) complementation assay, in which a yeast strain carrying a temperature-sensitive allele of the endogenous UBC9 gene exhibits loss of growth that can be rescued by expressing human UBE2I (Sun et al., 2016) . The impact of specific mutants or mutant combinations was assessed by the relative growth rate in a competitive growth assay. This high-throughput experiment measured over 5,000 UBE2I mutants (682 single mutations, and 4,427 distinct mutation combinations) for predictions.
We received 16 prediction datasets from nine groups. The assessment shows that most predictors are capturing qualitative (e.g., deleterious vs. benign) effects of mutations on proteins. However, the quantitative agreement between predictions and experimental measurements remains modest. The accuracy of predictions varies greatly among mutations and correlates strongly with the evolutionary signal in sequence alignment. While deleterious mutations at conserved positions are predicted best, predictions are poor for deleterious mutations at nonconserved positions and benign or beneficial mutations at conserved sites. Thus, significant improvements are needed and may come from more rigorous integration of features, better treatment of 3D structural information, consideration of epistatic effects, and analysis of interacting partners.
MATERIALS AND METHODS

UBC9 variant fitness measurements
For over 5000 human UBC9 protein variants, we used the scores measuring the ability of each variant human UBC9 protein to replace the function of yeast UBC9 in the context of a human-yeast complementation assay. Experimental data and a complete description of the DMSBarSEQ assay employed for this purpose are provided in a companion study by Weile et al. 2017. For each variant in the assay, a score was calculated, such that the score will be zero if a clone's fitness matches that of the mode of null controls, and it will be 1 if it matches the mode of wild-type UBC9 
Positive control and the baseline predictor
To provide a reference for predictions, we defined a positive and a baseline predictor control. The positive control was the "perfect" prediction one would expect when experimental errors were considered.
A prediction for each variant in the positive control was a randomly selected value from a Gaussian distribution with the given competitive growth score as mean and the experimental standard error as the standard deviation. The baseline predictor was based on the frequency of amino acids at each position in a UBC9 family multiple sequence alignment (MSA). The MSA was constructed using Promals3D (Pei & Grishin, 2014 ) from UBC9 and its 228 orthologs/inparalogs from the InPararoid (Sonnhammer & Ostlund, 2015) database (sequences and alignment are included in Supp. Material). For subsets 1 and 2, predictions were calculated using the following formula:
where Q m and Q w are the estimated probabilities of mutated and wildtype amino acids at a mutated position in the alignment as defined in, and P m and P w are Robinson-Robinson background frequencies (Robinson & Robinson, 1991) of the mutated and wild-type amino acids. For subset 3 with multiple mutations, we used the sum of the predictions for each single mutation.
Quantile transformation of original predictions
Most participants ignored calibrating their predictions using the distribution of experimental growth score given to them. Thus, rescaling of predictions was required to make predictors comparable in their scale, which is especially important for numeric comparison. We performed quantile transformation of the original predictions from participants and of our baseline predictor. Because predictors were not allowed to predict negative values and the negative competitive growth scores obtained in experiments did not show statistically significant difference from 0, all negative competitive growth scores were shifted to 0 before transformation. The mutations were ranked by the predicted values, and each mutation was assigned the experimental score with the same rank. The assigned experimental scores for mutants that are predicted to be ties are further averaged to obtain the final transformed predictions. 
Scores for prediction assessment
Evaluation of overall performance and its statistical significance
Four (three scores for ordinal association and AUC) of the measurements listed in Table 1 were purely based on rank and were not sen- value-based, and transformed-value-based measurements were computed and summed up to be the final score to assess the performance on each subset. The final assessment score was a weighted sum of the scores from three subsets. Because the experimental competitive scores in subset 1 were more accurate (with replicates) than those in subsets 2 and 3, subset 1 was weighted twice as much as the other two subsets.
To take experimental errors into consideration, we assumed that the growth score for each mutant in a dataset (subsets 1, 2, and 3)
can be randomly drawn from a Gaussian distribution defined by the reported growth score and the standard error. We repeated this procedure 1,000 times to generate 1,000 derived datasets from subset 1. Then, we performed bootstrap resampling on each derived dataset 40 times, and thus generated 40,000 samples from subset 1. Similarly, we obtained 40,000 samples from subset 2 but just 200 samples (40 derived datasets each resampled five times with bootstrap) for subset 3 due to time constraints required by the large number of mutants in it.
We randomly chose three simulated samples from subsets 1, 2, and 3 to form a new test set. A total of 40,000 new test sets were generated and used to assess the predictors using the same procedure as described above. We obtained the distribution of ranks for each group on these test sets. In addition, for each pair of groups, we compared their performance on each of the new test sets and counted their number of wins (head-to-head test).
Identification and characterization of well-predicted and poorly predicted variants
The absolute difference between the experimental score and transformed prediction was used to assess the prediction quality for each mutation by each group. A heat map was plotted and visualized by ClustVis (Metsalu & Vilo, 2015) to illustrate the prediction quality of each mutation from every predictor and the baseline prediction control. To find common properties shared by well-predicted and poorly predicted variants, we calculated conservation by AL2CO (Pei & Grishin, 2001 ) and relative solvent accessibility of residues by DSSP (Kabsch & Sander, 1983) .
RESULTS
UBE2I mutation bias toward being deleterious to competitive growth
The effect of variants in the single-mutation high-accuracy subset 1 on competitive growth is illustrated in Figure 1A . Out of 219 variants, six without a given competitive growth score or standard error were excluded from the analysis. The competitive growth scores were scaled so that mutant clones with growth identical to a null control were 0 and those with growth identical to a wild-type control were 1. 41% of all high-accuracy subset 1 mutations were deleterious (Fig. 1A ).
The remaining single amino acid variants (subset 2, 410 informative mutations) without replicates followed a similar distribution (Supp. 
Deleterious and advantageous mutations mapped to the UBE2I structure suggest functional effects
High-accuracy subset 1 deleterious mutations mapped to the UBE2I structure distribute across the surface ( (R j − j) is the count of true deleterious mutations that are ranked no worse than the j th true nondeleterious mutation. Each true deleterious mutation ranked the same as the j th true nondeleterious mutation is counted as 0.5. 
Ordinal association
Kendall tau-b rank correlation
; n c , the number of concordant pairs; n d , the number of discordant pairs; n, the total number of pairs; t k , number of values in the k th group of ties by predictions; u j , number of values in the j th group of ties by experimental scores.
, covariance between predicted and experimental ranks of mutants; R pred and R exp , standard deviations of predicted and experimental ranks, respectively. Ties were randomly assigned distinct ranks first and then the average of these ranks were assigned to each of them.
Rank agreement test
∑ Ci is the number of mutants with the difference between the predicted and experimental ranks below a certain cutoff i, 0≤i≤n-1, where n is the total number of mutations in a data set. Ties were randomly assigned distinct ranks. This random assignment was performed 50 times and the resulting scores were averaged.
Numeric comparison
Pearson's correlation cov(pred, exp)∕ pred exp , cov(pred, exp), covariance between predictions and experimental scores; pred , standard deviation of predictions; exp , standard deviation of experimental scores
N, the size of a dataset; pred j , j th predictions; exp j , j th experimental scores
Value agreement test
∑ Ci is the number of mutants with the difference between the predicted and experimental growth scores below a certain cutoff i. The cutoffs are taken from 0 to the number larger than maximal difference between experimental and predicted growth scores in the dataset, with an increment of 0.01. The normalized area was used as the measurement.
mutation of the adjacent Y87 to H results in an intermediate growth phenotype with a score (0.318) close to the deleterious boundary. The distribution of these mutations near the active site suggests that correct positioning of the substrate lysine is required for wild-type UBE2I
activity. As such, a distribution of all variants that include the active site C93 tends to surround the null score 0, with some of the multiple variants extending slightly toward wild-type growth scores (Supp. Fig.   S1B ). The distribution of all variants that include the adjacent D127
is similar to that of the active site C93, except it includes a minor tail that extends toward higher competitive growth scores (Supp. A wealth of UBE2I structure information exists to aid in mutation prediction, including the UBE2I structure alone and numerous complex cocrystal structures. Inspection of the cocomplexes superimposed using UBE2I highlights binding surfaces on the ligase that overlap with mapped mutations. Quaternary complex structures with RanGap1 substrate, E3 ligase RanBP2 fragments, and SUMO1/2 show subtle conformational changes that help the E3 ligase achieve SUMO specificity (Gareau, Reverter, & Lima, 2012) (Fig. 2) . In this quaternary complex, the SUMO C-terminus is poised to modify the RanGap1 substrate lysine, and the RanBP2 E3 fragments adopt an extended conformation with the N-terminus wrapping around SUMO and C-terminus wrapping around UBE2I. In addition to the substrate lysine binding residues described above, several deleterious mutations map (within (12 with relatively severe alterations from the native structure). The F I G U R E 2 Advantageous growth mutations. The Ubc9 (green cartoon) structure complex (PDB: 3uio) bound to RanGAP1 (magenta cartoon), SUMO2 (cyan cartoon), and the E3 ligase IR1 domain of RanBP2 (yellow cartoon) highlights positions of residues with advantageous growth mutations (red spheres, labeled according to WT position) with respect to the active site Cys (black sphere) and the consensus substrate tetrapeptide E and K residues (magenta spheres)
presence of numerous deleterious mutations in the importin interface suggests that USB9 localization to the nucleus is required for the growth phenotype.
The relatively smaller proportion of high-accuracy subset 1 mutations that are advantageous for growth also distribute across the UBE2I surface, with two of the residues being near the active site (T91 and E98). A distribution of competitive growth scores for all variants that include E98 shifts toward higher scores, displaying a broad second peak in the advantageous growth category (Supp. Fig. S1C ).
Interestingly, both T91 and E98 can provide substrate contacts. For example, T91 forms hydrogen bonds with the consensus substrate tetrapeptide E, whereas E98 approaches a K just N-terminal to the conserved consensus tetrapeptide in one available UBE2I structure bound to substrate (PDB: 5d2m). Two of the activating mutations, K74 and K65, belong to a basic patch that discriminates negatively charged amino acid-dependent sumoylation motif (NDSM) substrates (Yang, Galanis, Witty, & Sharrocks, 2006) . These NDSM substrates include an additional defined motif PsiKxE(xxSP) whose conserved S gets phosphorylated to promote sumoylation of several substrates (Hietakangas et al., 2006) . Thus, activating mutations appear to discriminate between sumoylation substrates, potentially shifting activity away from phosphorylation-dependent substrates and toward those alternate substrates that contribute to competitive growth.
Negative growth scores and disparate distributions of predicted scores are a challenge for the assessment
Many clones grew slower than the null control, resulting in negative growth scores. FDR-corrected t-tests based on the regularized standard deviations showed that none of these clones' growth scores were significantly different from the null controls. Thus, predictors were not allowed to assign negative growth scores. Unfortunately, this rule required reassignment of all the experimental mutations with negative growth scores. In an attempt to best accommodate predictions provided by participating groups (Fig. 3) , negative growth scores were shifted to 0, since most of the groups (11 out of 16) submitted multiple 0's, and none of them submitted negative predictions. Such a reassignment of experimental growth scores resulted in many ties and required special attention to ties in the assessment (see Materials and Methods).
Although the groups were given the distribution of growth scores for each of the subsets, their distributions tended to be significantly different from the experimental distribution, with most of the groups (13) having a Kolmogorov-Smirnov test P value less than 0.1 (Supp. the experimental results, and the evaluation was done on both the original and the transformed predictions.
Assessment revealed modest performance comparable between the predictors
The predictors were evaluated by their ability to (1) classify mutations into fitness categories, (2) rank mutations by their effects on fitness (i.e., competitive growth rate of yeast), and (3) numerically predict competitive growth scores of mutants (Table 1) . Table 2 summarizes the overall performance of the predictors on three subsets. All participants except group 45 show significantly better than random performance, with the best performing groups being able to rank about 67% (Kendall-tau rank correlation coefficient: 0.338) pairs of single mutants correctly (Supp. Table S2 ). The RMSD between transformed predictions and experimental scores is significantly better than random for all groups except group 45 (P > 0.05 for both original and transformed predictions). The results show a definite promise of predicting fitness effects of mutations. However, the current accuracy of the predictions is rather low, which is revealed by the large gap between the positive control (see Materials and Methods) and predictions. The performances on subsets 1 and 2 (single mutation) are comparable, and are significantly better than that on subset 3 (multiple substitutions), reflecting the difficulty in predicting effects of multiple mutations.
Group 43 consistently outperformed most other methods across the three subsets, ranking first in the final assessment. Group 47 was best performing in subset 1, but was relatively poor in predicting the effect of multiple mutations. Surprisingly, the performance of our baseline predictor that uses only amino acid frequencies from the multiple alignment was better than many of the more complex predictors on all subsets, ranking second in the overall assessment. To assess how the ranking of predictors is affected by experimental errors or by the set of mutants obtained in the experiment, we performed the same assessment on 40,000 additional simulated experimental datasets (contains subsets 1, 2, and 3, see Materials and Methods). The distribution of the ranks for predictors on these simulated datasets is shown in Figure 4A .
Except group 43, all others revealed a wide distribution in ranks. Similarly, head-to-head test (Supp. Fig. 2A) shows that group 43 ranks better than all other participants on over 99% of simulated datasets, and it ranks better than our baseline control on 90% of the simulated datasets.
However, the superior performance of groups 43-47 mainly results from its better ability in predicting the effect of multiple mutations (subset 3). For subset 3, Pearson's or Spearman's correlation coefficients are significantly different between group 43 and other predictors (44, 46, 47; P < 0.05). In contrast, except groups 45 and 42, the ability for participants to predict the effects of single mutants (subsets 1 and 2) is comparable ( Fig. 2B ).
Predictors are adequate at detecting deleterious mutations
One of the primary goals for the prediction of mutation effects is to identify deleterious mutations. Thus, we specifically evaluated predic- . Table S4 ) between predictions and experimental scores when deleterious mutations were excluded from subset 1.
Identification and characterization of mutations predicted well and poorly
The heat map of prediction quality by each group on each mutant in subset 1 is shown in Figure 5A . The mutants form three clusters on the heat map: variants that are well or poorly predicted by almost all predictors formed clusters 1 and 3 (Supp. Fig. S3 ), whereas cluster 2 contained mutations well or poorly predicted only by some predictors. In accordance with the performance on classification of mutations reflected by MCC, most poorly predicted variants were advantageous, whereas most well-predicted variants were deleterious.
Nevertheless, some deleterious mutations were poorly predicted.
These mutations were at positions that are less conserved and more accessible to solvent. On the contrary, among wild-type mutations, poorly predicted ones were more conserved with lower relative solvent accessibility than the well-predicted mutations (Fig. 5B ). In And, interestingly, many substitutions of residues K65, K74, and K76 responsible for interactions between UBE2I with RanGAP1 showed beneficial effects in yeast complementation assays. In addition, these residues are also responsible for recognizing phosphorylated substrates (Gareau & Lima, 2010) . Due to the absence of interacting partners in yeast, it is unclear whether these variants would have the same effects in human. For variants of the catalytic site position (C93), the yeast complementation assay showed functional disruptions similarly to human cells (Lin et al., 2002) . In subsets 1 and 2, all variants at the catalytic site were nearly null. The variants at R13 and R17, residues important for interaction with SUMO1 and nuclear import of UBE2I (Tatham et al., 2003) , were also deleterious in subsets 1 and 2. Thus, the yeast complementation assay can be used to identify functional effects of variants with certain limits. This uncertainty is expected to F I G U R E 5 Performance evaluation on single mutations. A: The absolute difference between experimental competitive growth scores and that predicted by each group method (using transformed data), as well as a baseline predictor (cont) based on residue frequency in multiple alignment, were calculated to reflect prediction quality for each mutation in subset1. Difference data were uploaded to the ClustVis Web tool to visualize the corresponding heatmap, with mutations (horizontal axis) colored from red (high difference) to blue (low difference). Mutations were clustered (depicted as a tree above the heatmap) using Euclidean distance with Ward minimum variance method linkage criterion. The three largest clusters correspond to overall poor prediction quality (red), intermediate prediction quality (green), and good prediction quality (blue). B: Group 1 poorly predicted mutations (left, labeled below) and group 3 well-predicted mutations (right, labeled below) were split into growth performance categories according to experimental growth score: deleterious, intermediate, wild type, and advantageous (none in well-predicted mutations). Properties of the categorized mutations are illustrated in a bar chart: the frequency of mutations in each category with respect to the total in the group (blue bars, fraction), the average conservation fraction (red bars, conservation) measured by Al 2 Co, and the average solvent accessibility fraction (green bars, surface) measured by DSSP be resolved in future CAGI by using unpublished clinical data or data from human-derived cell lines.
Another problem arising in the CAGI assessment was the difference in numeric scale of predictions. Different numeric scales of predictions can skew the performance. For example, the shrinkage of numeric prediction scale may lead to better RMSD, which does not necessarily reflect better predictions. We tried several transformation methods, including normalization and standardization; however, they did not lead to consistent results in numeric comparison. Therefore, the assessment was affected by transformation and there were possible biases introduced. However, compared with other rescaling methods, our choice of directly assigning experimental competitive scores to predictions by comparing ranks was expected to minimize the differences between prediction and experimental score distributions. To address possible biases of score transformations, we introduced binary classification and ordinal association scores, which were more tolerant to numeric differences. We also evaluated scores for both original and transformed predictions and included them in the assessment to offset the concerns triggered by transformation. All of these score choices were aimed at removing bias and resulted in reasonable assessments.
To address the problem in the future CAGI, a standard and agreed upon rescaling procedure for submitted predictions could be automatically applied when participants submit their results.
Participants of CAGI4 included five published predictors: SAVER (Adebali et al., 2016 ) (group 40), SNAP (Bromberg & Rost, 2007) (Remmert, Biegert, Hauser, & Soding, 2011) and PSI-BLAST (Altschul et al., 1997) (Capriotti & Altman, 2011; Kumar et al., 2009; Saunders & Baker, 2002; Schaefer & Rost, 2012) . While some previous studies implied that addition of protein structure considerations to predictions only marginally elevates the performance (Kumar et al., 2009; Saunders & Baker, 2002) , others claimed the introduction of protein structures led to 6% improvements (Capriotti & Altman, 2011) . It is possible that the usefulness of protein structures for predictions depends on the protein of interest, the positions of variants, or even on the quality of sequence conservation analysis performed by a predictor. More comprehensive studies are expected to clarify whether the introduction of structural features can contribute to better predictions.
For subset 3, where each target is a combination of single variants, the performance of predictors decreased. Different summation schemes of predictions on single variants were used to assign the final prediction to the target. The best-performing group 43 in subset 3 assigned the sum of the predictions of single variants to the target, whereas group 47, which scored best in subset 1, assigned predictions of most deleterious variant to the target. The discrepancy in performance between these groups suggested that the effects of multiple mutations on fitness may be additive and should be taken into account.
However, experiments with our baseline predictor did not support this explanation. We compared the performance of two baseline predictors: the one that assigns the sum of scores for all mutations with the one that assigns the minimal score (i.e., most deleterious mutation only). The performance of the two predictors did not differ significantly (Kendall tau-b values for correlation between predictions and experimental data were 0.17 and 0.18). In addition, the Pearson's correlation between the two controls was 0.91, suggesting highly similar predictions. Therefore, it remains unclear whether the consideration on additive effects of variants was the major reason that group 43 had the best performance in subset 3. However, the results from our baseline predictor may not be generalizable, because the effect of summation scheme on performance may depend on specifics of how predictions for single variants are computed.
Notably, many variants have high standard errors even in subset 1 (with several replicates). The small number of replicates is a possible reason. However, the distributions of experimental competitive growth scores for both null mutants and wild-type clones with more than three replicates also showed a wide distribution, implying varying responses from individuals with the same mutation. Such dispersion may be reflective of the measurement precision one might expect in a growth-based assay.
In summary, the SUMO conjugase challenge highlights better performance of methods for predictions of deleterious mutations at conserved sites, the type of mutations that is highly likely to cause disease.
It also reveals that substantial improvements of predictions are needed to predict deleterious variants at nonconserved sites and benign mutations at conserved sites.
